EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V108. A total of 28 filers reported holding EFFECTOR THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $545 | -92.6% | 1,168 | -90.5% | 0.00% | – |
| Q3 2023 | $7,400 | -14.2% | 12,334 | +18.8% | 0.00% | – |
| Q2 2023 | $8,620 | +215400.0% | 10,385 | +0.7% | 0.00% | – |
| Q1 2023 | $4 | -60.0% | 10,316 | -54.6% | 0.00% | – |
| Q4 2022 | $10 | -99.9% | 22,728 | +38.5% | 0.00% | – |
| Q3 2022 | $9,000 | -18.2% | 16,407 | +119.4% | 0.00% | – |
| Q2 2022 | $11,000 | +450.0% | 7,478 | +1264.6% | 0.00% | – |
| Q1 2022 | $2,000 | -71.4% | 548 | -25.6% | 0.00% | – |
| Q4 2021 | $7,000 | -92.8% | 737 | -89.3% | 0.00% | -100.0% |
| Q3 2021 | $97,000 | – | 6,859 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 6,822,114 | $27,357,000 | 14.00% |
| Abingworth LLP | 4,822,114 | $18,903,000 | 5.36% |
| Column Group LLC | 4,309,329 | $17,280,000 | 3.20% |
| OUP Management Co., LLC | 1,025,697 | $4,113,000 | 3.13% |
| SECTORAL ASSET MANAGEMENT INC | 2,382,744 | $9,555,000 | 1.70% |
| Parallel Advisors, LLC | 677,452 | $2,744,000 | 0.11% |
| Oasis Management Co Ltd. | 100,000 | $401,000 | 0.06% |
| Blackstone Inc. | 1,308,587 | $5,248,000 | 0.01% |
| ALPS ADVISORS INC | 46,537 | $187,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 548 | $2,000 | 0.00% |